InvestorsHub Logo
Followers 130
Posts 21787
Boards Moderated 0
Alias Born 06/13/2011

Re: ORBAPU post# 381810

Thursday, 06/30/2022 8:03:31 PM

Thursday, June 30, 2022 8:03:31 PM

Post# of 433958

CONCLUSIONS:
Among participants in REDUCE-IT, allocation to icosapent ethyl had minimal effects on a series of biomarkers associated with atherosclerotic disease, whereas levels increased among those allocated to mineral oil. The effect of these findings on interpretation of the overall risk reductions in clinical events observed within REDUCE-IT is uncertain.



Levels increased among those allocated to mineral oil ...but U figure something else caused this ?

I'm not saying there is no risk reduction from taking Vascepa ...I still take it ...just doubt its as good as the R-IT results claim

Kiwi
0.40
-0.01 (-2.44%)
Volume: 1,451,566
Day Range: 0.40 - 0.4281
Bid: 0.40
Ask: 0.414
Last Trade Time: 4:11:13 PM EDT
Total Trades: 1,724
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News